Uwe Albrecht, MD, the Managing Director at Mediconomics, recently sat down with partnering 360® to share what his company is focusing on and how they're helping companies with clinical trials traverse the difficult waters of international regulation. Regulations have caused ongoing safety reporting to take more time - and this is where the company comes into play.
Mediconomics has developed a program that allows for companies to know they can have all the data they need from their clinical trials when they need it. The company also prides itself on understanding and turning around projects for clinical trials in Germany - a country whose regulations are far stricter than many other countries most companies work in. Find out more about the company's specialty in clinical trials at Insight.
What do you find is the most difficult part of data collection when applying for clinical approval across multiple countries?
The Partnerships in Clinical Trials Blog focuses on optimization intelligence, regulatory trends and globalization strategies for both sponsors and CROs. It is supported by a number of industry events.
Would you like to guest blog on our site? Or send us feedback? Send an email to email@example.com.